Dumulon-Perreault V - Search Results

1

Evaluation of 64Cu-labeled bifunctional chelate-bombesin conjugates.

Ait-Mohand S, Fournier P, Dumulon-Perreault V, Kiefer GE, Jurek P, Ferreira CL, Bénard F, Guérin B. Ait-Mohand S, et al. Bioconjug Chem. 2011 Aug 17;22(8):1729-35. doi: 10.1021/bc2002665. Epub 2011 Jul 29. Bioconjug Chem. 2011. PMID: 21761921

2

Total solid-phase synthesis of NOTA-functionalized peptides for PET imaging.

Guérin B, Ait-Mohand S, Tremblay MC, Dumulon-Perreault V, Fournier P, Bénard F. Guérin B, et al. Org Lett. 2010 Jan 15;12(2):280-3. doi: 10.1021/ol902601x. Org Lett. 2010. PMID: 20014826

3

[Lys(DOTA)4]BVD15, a novel and potent neuropeptide Y analog designed for Y1 receptor-targeted breast tumor imaging.

Guérin B, Dumulon-Perreault V, Tremblay MC, Ait-Mohand S, Fournier P, Dubuc C, Authier S, Bénard F. Guérin B, et al. Bioorg Med Chem Lett. 2010 Feb 1;20(3):950-3. doi: 10.1016/j.bmcl.2009.12.068. Epub 2009 Dec 23. Bioorg Med Chem Lett. 2010. PMID: 20042335

4

Comparative study of 64Cu/NOTA-[D-Tyr6,βAla11,Thi13,Nle14]BBN(6-14) monomer and dimers for prostate cancer PET imaging.

Fournier P, Dumulon-Perreault V, Ait-Mohand S, Langlois R, Bénard F, Lecomte R, Guérin B. Fournier P, et al. EJNMMI Res. 2012 Feb 14;2:8. doi: 10.1186/2191-219X-2-8. EJNMMI Res. 2012. PMID: 22333272 Free PMC article.

5

Novel radiolabeled peptides for breast and prostate tumor PET imaging: (64)Cu/and (68)Ga/NOTA-PEG-[D-Tyr(6),βAla(11),Thi(13),Nle(14)]BBN(6-14).

Fournier P, Dumulon-Perreault V, Ait-Mohand S, Tremblay S, Bénard F, Lecomte R, Guérin B. Fournier P, et al. Bioconjug Chem. 2012 Aug 15;23(8):1687-93. doi: 10.1021/bc3002437. Epub 2012 Jul 25. Bioconjug Chem. 2012. PMID: 22770480

6

[(11)C]-Acetoacetate PET imaging: a potential early marker for cardiac heart failure.

Croteau E, Tremblay S, Gascon S, Dumulon-Perreault V, Labbé SM, Rousseau JA, Cunnane SC, Carpentier AC, Bénard F, Lecomte R. Croteau E, et al. Nucl Med Biol. 2014 Nov-Dec;41(10):863-70. doi: 10.1016/j.nucmedbio.2014.08.006. Epub 2014 Aug 13. Nucl Med Biol. 2014. PMID: 25195015

7

PACE4-based molecular targeting of prostate cancer using an engineered ⁶⁴Cu-radiolabeled peptide inhibitor.

Couture F, Levesque C, Dumulon-Perreault V, Ait-Mohand S, D'Anjou F, Day R, Guérin B. Couture F, et al. Among authors: dumulon perreault v. Neoplasia. 2014 Aug;16(8):634-43. doi: 10.1016/j.neo.2014.07.010. Neoplasia. 2014. PMID: 25220591 Free PMC article.

8

Impact of dianionic and dicationic linkers on tumor uptake and biodistribution of [⁶⁴ Cu]Cu/NOTA peptide-based gastrin-releasing peptide receptors antagonists.

Mansour N, Dumulon-Perreault V, Ait-Mohand S, Paquette M, Lecomte R, Guérin B. Mansour N, et al. Among authors: dumulon perreault v. J Labelled Comp Radiopharm. 2017 Apr;60(4):200-212. doi: 10.1002/jlcr.3491. Epub 2017 Mar 5. J Labelled Comp Radiopharm. 2017. PMID: 28129446

9

Evaluation of a novel GRPR antagonist for prostate cancer PET imaging: [⁶⁴Cu]-DOTHA₂-PEG-RM26.

Mansour N, Paquette M, Ait-Mohand S, Dumulon-Perreault V, Guérin B. Mansour N, et al. Among authors: dumulon perreault v. Nucl Med Biol. 2018 Jan;56:31-38. doi: 10.1016/j.nucmedbio.2017.10.006. Epub 2017 Oct 23. Nucl Med Biol. 2018. PMID: 29154145

10

Promising Performance of 4HMS, a New Zirconium-89 Octadendate Chelator.

Alnahwi AH, Ait-Mohand S, Dumulon-Perreault V, Dory YL, Guérin B. Alnahwi AH, et al. Among authors: dumulon perreault v. ACS Omega. 2020 May 5;5(19):10731-10739. doi: 10.1021/acsomega.0c00207. eCollection 2020 May 19. ACS Omega. 2020. PMID: 32455192 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

18 results

Search Page

Filters